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Abstract
 
Cytotoxic T lymphocyte antigen (CTLA)-4 plays an essential role in immunologic homeosta-
sis. How this negative regulator of T cell activation executes its functions has remained contro-
versial. We now provide evidence that CTLA-4 mediates a cell-intrinsic counterbalance to re-
strict the clonal expansion of proliferating CD4
 
 
 
 T cells. The regulation of CTLA-4 expression
and function ensures that, after 
 
 
 
3 cell divisions of expansion, most progeny will succumb to
either proliferative arrest or death over the ensuing three cell divisions. The quantitative preci-
sion of the counterbalance hinges on the graded, time-independent induction of CTLA-4 ex-
pression during the first three cell divisions. In contrast to the limits imposed on unpolarized
cells, T helper type 1 (Th1) and Th2 effector progeny may be rescued from proliferative arrest
by interleukin (IL)-12 and IL-4 signaling, respectively, allowing appropriately stimulated prog-
eny to proceed to the stage of tissue homing. These results suggest that the cell-autonomous
regulation of CTLA-4 induction may be a central checkpoint of clonal expansion of CD4
 
 
 
 T
cells, allowing temporally and spatially restricted growth of progeny to be dictated by the na-
ture of the threat posed to the host.
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Introduction
 
Proliferation and differentiation of CD4
 
 
 
 T cells are regu-
lated by numerous extrinsic signaling pathways. Variables
such as the amount of antigen, inflammation, costimula-
tory ligands, and cytokine milieu all serve to multiply the
potential outcomes of an immune response (1). Despite
the seemingly limitless possibilities, there are certain be-
haviors of activated CD4
 
 
 
 T cells that suggest a level of in-
variant, autonomous control (2, 3). One strikingly uniform
feature in the activation of helper T cells is the finding that
clonal expansion seems invariably accompanied by clonal
contraction (4). Activation-induced cell death is generally
regarded as the major mechanism for lymphocyte homeo-
stasis during an immune response (5–7). CD4
 
 
 
 T cells can
be induced to undergo apoptosis through a mechanism
that is linked to their activation, but how the processes are
coupled is not well understood. Whether nonapoptotic
mechanisms exist to limit lymphocyte expansion is also
uncertain (8).
The phenotype of cytotoxic T lymphocyte antigen 4
(CTLA-4)
 
*
 
 deficiency in mice (9–11) suggests that this re-
ceptor plays a central role in homeostasis. Together with
other gain- and loss-of-function experiments, CTLA-4 has
been implicated as a regulator of cell cycle (12–14), anergy,
tolerance (15–17), autoimmunity (18), transplantation (18),
effector choice (19–21), and immunity to tumors (22) and
foreign pathogens (23–25). One explanation for how nega-
tive regulation by CTLA-4 might be involved in many dis-
parate immunologic reactions is that its regulation and
function are coupled to the proliferative program. It has
become evident that the cell cycle organizes some changes
in gene expression in CD4
 
 
 
 T cells that are critical for ef-
fector subset choice (26–28) and effector-memory homing
(29, 30). This suggests that many immunologic reactions,
despite being cued by extrinsic variables, have levels of cell-
autonomous control that are determined by the lineage re-
lationship of proliferating cells (2–4).
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We wished to determine the precise lineage relationship
between cells that were engaged in a proliferative response
when well-characterized variables of activation were ex-
perimentally manipulated. Using the dilution of carboxy-
fluorescein diacetate succinimidyl ester (CFSE) to assess cell
division (31), in conjunction with quantitation of cellular-
ity and apoptosis, CD4
 
 
 
 T cells were found to have a cell-
intrinsic mechanism to control their proliferation. The
control mechanism can be ascribed to the graded, cell cy-
cle–coupled regulation of the expression and function of
the CTLA-4 receptor. These findings suggest that vastly
different immunologic outcomes mediated by CD4
 
 
 
 T
cells result from the integration of extrinsic stimuli with a
cell-autonomous program of gene regulation that is linked
to cell division.
 
Materials and Methods
 
Mice.
 
Wild-type C57BL/6 and BALB/c mice were obtained
from The Jackson Laboratory. CTLA-4
 
 
 
/
 
 
 
 (9), CD28
 
 
 
/
 
 
 
 (32),
BCl-x
 
L
 
 (under the control of the CMV promoter and E
 
 
 
 en-
hancer) transgenic (33), and DO11.10 TCR transgenic (34) mice
were generated as described. CTLA-4
 
 
 
/
 
 
 
 DO11.10 TCR trans-
genic mice were used to delay onset of disease in CTLA-4
 
 
 
/
 
 
 
 an-
imals (17, 35), and wild-type DO11.10 TCR transgenic, CD28
 
 
 
/
 
 
 
DO11.10 TCR transgenic, and Bcl-x
 
L
 
 transgenic DO11.10 TCR
transgenic mice were used as their controls. All mutant mice were
backcrossed to the BALB/c or B10.D2 background six times be-
fore intercross with mice from the same background. Animals
were genotyped using PCR and flow cytometry. All animal work
was done in accordance with guidelines of the University of
Pennsylvania.
 
Cell Culture.
 
In experiments with nontransgenic mice, sple-
nocytes were depleted of CD8
 
 
 
 cells using magnetic beads
(PerSeptive Biosystems), and stimulated (2 
 
 
 
 10
 
6
 
 cells/ml) us-
ing soluble anti-CD3 mAb (2.0 
 
 
 
g/ml; BD PharMingen) as
described (26), unless indicated. Anti-CD28 mAb (BD Phar-
Mingen), human rIL-2 (Life Sciences), murine rIL-4 (Roche),
rIL-12 (BD PharMingen), anti–IL-4 mAb (BD PharMingen),
and anti–IL-12 mAb (BD PharMingen) were used at concen-
trations indicated in the figure legends. Stimulations of
DO11.10 transgenic splenocytes were performed as described
for wild-type cells, except without prior CD8 depletion. All
cells were labeled with CFSE (Molecular Probes) as described
previously (26). Briefly, cells (2 
 
 
 
 10
 
7
 
 cells/ml) were incubated
in PBS with CFSE (5 
 
 
 
M) for 9 min at room temperature.
Labeling was quenched with an equal volume of FCS, and
then cells were washed twice with HBSS supplemented with
10% FCS.
 
Flow Cytometry.
 
Flow cytometric analysis was performed on
fixed cells as described previously (26). Briefly, cells were washed
with PBS and fixed in 4% paraformaldehyde for 11 min at room
temperature. Fixed cells were stained in permeabilization buffer
(PBS with 0.2% saponin, 1% FCS, and 0.1% sodium azide). Phy-
coerythrin-conjugated mAbs against CTLA-4, CD25, CD44, and
allophycocyanin-conjugated mAbs against IFN-
 
 
 
 and IL-4 were
used where indicated. For intracellular cytokine staining only,
cells were restimulated with PMA (50 ng/ml; Sigma-Aldrich) and
ionomycin (500 ng/ml; Sigma-Aldrich) for 4 h, with brefeldin A
(2.0 
 
 
 
g/ml; Sigma-Aldrich) added for the final 2 h, before fixa-
tion.
Live, unfixed cells were washed in HBSS 1% FCS before
staining. All antibodies were obtained from BD PharMingen, un-
less indicated. Flow cytometry was performed using a Becton
Dickinson FACSCalibur™ instrument and CELLQuest™ soft-
ware. Throughout the article, data represent only CD4
 
 
 
 events,
based on specific staining with fluorochrome-conjugated anti-
CD4 mAbs (Caltag). Unless specified, analysis includes only live
(as determined by forward and side light scatter), CD4
 
 
 
 events.
Gates for specific staining of surface or intracellular proteins were
determined using fluorochrome-conjugated species-matched and,
where possible, isotype-matched, control mAbs.
 
Cell Death and DNA Content.
 
Binding of PE-conjugated
Annexin V (BD PharMingen) was performed on unfixed cells ac-
cording to the manufacturer’s instructions. Propidium iodide
(P.I.) exclusion was performed by resuspending unfixed cells in
PBS with P.I. (1.0 
 
 
 
g/ml; Sigma-Aldrich) 5 min before flow cy-
tometry. ToPro-3 (Molecular Probes) was used to assess DNA
content in fixed, permeabilized cells. Cells were first stained with
mAbs, and then washed, fixed, and incubated in PBS with sapo-
nin (0.3%), RNase A (50 
 
 
 
g/ml), EDTA (5 mM), and ToPro-3
(1.0 
 
 
 
M) for 30 min at 4
 
 
 
C before analysis by flow cytometry.
 
Reverse Transcription PCR of CC Chemokine Receptor 7 Expres-
sion.
 
CD8-depleted, CFSE-labeled cells were stimulated for 4 d
in the cytokine conditions indicated in the figure legend, and
then stained with fluorochrome-conjugated anti-CD4 mAb, be-
fore sorting of live-gated, CD4
 
  
 
events into separate generations
by flow cytometry, using a MoFlo instrument (Cytomation).
Cells were washed and total RNA was extracted using Trizol
Reagent (Life Technologies) and reverse transcribed using ran-
dom hexamer primers (Amersham Pharmacia Biotech), as de-
scribed (36). cDNA levels were equalized by reverse transcription
(RT)-PCR, using a competitive template of hypoxanthine gua-
nine phosphoribosyl transferase (HPRT) cDNA as an internal
standard, as described (36). The competitive template, because of
its higher molecular weight, migrates slower than authentic
HPRT cDNA during electrophoresis. PCR for CC chemokine
receptor (CCR)7 was performed on equalized cDNA samples.
Each reaction was performed at least three times. The following
primer sets were used: CCR7 sense CTACAGCCCCCAGAG-
CACCAT, CCR7 antisense GAAGGGAAGAATTAGGAG-
GAAAAG, HPRT sense GTTGGAGACAGGCCAGACTT-
TGTTG, and HPRT antisense GAGGGTAGGCTGGCC-
TATAGGCT.
 
Results
 
Limits on Clonal Expansion Are Regulated by the Cell Divi-
sion Cycle.
 
CFSE labeling was used to resolve individual
cell divisions by the quantitative dilution of green fluores-
cence that accompanies cytokinesis (31). CD8-depleted
splenocytes were stimulated with soluble anti-CD3 mAb,
using endogenous accessory cells to cross-link the anti-
CD3 mAb and provide a natural source of ligands for
CD28 and CTLA-4. We first performed a quantitative
analysis of relative cellularity as a function of cell division in
an asynchronously dividing population that encompassed at
least five cell divisions. By comparing the relative number
of live CD4
 
 
 
 T cells in each successive division, we found
that the dynamics of clonal expansion follow a highly re-
producible pattern over a range of conditions (Fig. 1). The
greatest number of cells was typically found in the popula- 
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tion having completed the third or fourth cell division.
Although many cells continued through 1–3 more cell di-
visions, cellular expansion was limited not only by prolifer-
ative arrest, but apoptosis (see below). As a result, fewer
than 5% of the viable cells in culture completed the sixth
cell division.
Changes in mitogenic dose of anti-CD3 mAb (0.05–5.0
 
 
 
g/ml), duration of culture (3–6 d), and genetic back-
ground of T cells did not alter the pattern of clonal expan-
sion (Fig. 1 A), suggesting that this regulatory mechanism is
independent of both responder frequency and time. Addi-
tion of varying concentrations of anti-CD28 mAb (0.3–
10.0 
 
 
 
g/ml) under the same mitogenic conditions shifted
the point of maximal cellularity to a later cell division (Fig.
1 A). The increase in cell expansion that resulted from co-
stimulation, however, did not result from expansion of cells
past the fifth division, and, again, fewer than 5% of cells
successfully completed the sixth division.
The distribution of cell death within discrete cell divi-
sions was examined by analyzing the binding of Annexin
V to apoptotic membranes (Fig. 1 B). As expected, there
was significant cell death among activated, proliferating
cells. We consistently observed, however, that the major-
ity of apoptosis occurred after the third cell division, and
increased substantially in later cell divisions (Fig. 1 B).
Identical results were obtained using exclusion of propid-
ium iodide as a parameter of survival (see below). Thus,
over a wide range of conditions, clonal expansion of
CD4
 
 
 
 T cells is limited by a combination of cell cycle ar-
rest and apoptosis.
 
CTLA-4 Limits Clonal Expansion.
 
The fact that each
experiment followed the same fundamental pattern was
quite unexpected since the incorporation of radioactive
thymidine yielded orders-of-magnitude differences be-
tween the experimental variables we employed (data not
shown). Although CD28 costimulation could increase the
percentage of cells that complete the fifth division before
arresting and dying, there appeared to be an absolute bar-
rier past which cells did not proceed, or if they did, under-
went apoptosis. This reproducible pattern under different
stimulatory conditions and at different time points suggests
the possibility that clonal expansion is limited by a divi-
sion-dependent counterbalance that is metered in a cell-
autonomous manner.
We observed both a failure to proceed past five divisions
and increasing cell death in later divisions even in cells that
were deficient in FAS (data not shown), suggesting that
FAS, although potentially important to subsequent cell
elimination, was not required for the termination of pro-
liferative expansion. CTLA-4
 
 
 
/
 
 
 
 mice were bred to
DO11.10 TCR transgenic mice, to delay the onset of dis-
ease seen in CTLA-4–deficient animals (17, 35). Although
CTLA-4
 
 
 
/
 
 
 
 cells from mice of this age may contain up to
fivefold more activated cells than wild-type cells (9), we
used only younger CTLA-4
 
 
 
/
 
 
 
 DO11.10 animals and ex-
cluded from analysis any mice with grossly enlarged spleens
or lymph nodes. CTLA-4
 
 
 
/
 
 
 
 DO11.10 TCR transgenic
cells were compared with those from DO11.10 TCR
transgenic mice, and CD28
 
 
 
/
 
 
 
 DO11.10 TCR transgenic
mice. CD4
 
 
 
 T cells from CD28
 
 
 
/
 
 
 
 mice had a profound
proliferative defect compared with normal cells (Fig. 2 A).
CD28
 
 
 
/
 
 
 
 cells did not achieve significant cellular expan-
sion, despite many precursors undergoing at least one divi-
sion, because many of the cells in culture underwent apop-
tosis (Fig. 2 A).
In contrast, T cells from CTLA-4
 
 
 
/
 
 
 
 mice divided at
least 2–3 divisions more than wild-type cells, and did not
show any evidence of reaching a clear limit of proliferative
cell division (Fig. 2 A). The proliferative arrest of wild-type
cells was accompanied by substantial apoptosis of cells that
completed multiple rounds of division, manifest as an in-
crease in propidium iodide uptake in the later cell divisions
(Fig. 2 A). In contrast, the unchecked clonal expansion of
CTLA-4
 
 
 
/
 
 
 
 cells correlated with decreased cell death in
the later divisions of proliferating cells (Fig. 2 A). The apex
of cellularity in CTLA-4
 
 
 
/
 
 
 
 cells occurred at even later di-
Figure 1. Uniformity in the clonal expansion of
CD4  T cells. (A) CD8-depleted, CFSE-labeled
splenocytes were stimulated (see Materials and Meth-
ods) with varying concentrations of anti-CD3 mAb
(0.05–5.0  g/ml), and analyzed on day 3, 4, 5 or 6
(top panel). Cellularity of live, CD4  cells, as deter-
mined by specific staining with anti-CD4 mAb, in
relation to cell division number is depicted graphi-
cally. For comparative purposes the number of cells
in each cell division as determined by CFSE dilution
(x-axis) was expressed as a percentage of the number
of cells in the cell division having the largest number of cells (y-axis) within each experimental condition. Top
panel includes 10 experiments (with each line representing one experimental condition and time point). Bottom
panel depicts 10 experiments (with each line representing one experimental condition and time point) using vary-
ing concentrations of both anti-CD3 (0.01–2.0  g/ml) and anti-CD28 (0.3–10.0  g/ml) mAbs, all analyzed on
day 4. Cells from both C57BL/6 and BALB/c mice were tested. Dose responses of anti-CD3 and anti-CD28 were
tested at least twice. (B) CD8-depleted, CFSE-labeled splenocytes were stimulated with anti-CD3 mAb (1.0  g/
ml), anti-CD28 mAb (2.0  g/ml), and rIL-2 (2 U/ml) for 3 d, and stained with fluorochrome-conjugated An-
nexin V and anti-CD4 mAb. Binding of Annexin V (“% Apoptotic,” y-axis) among CD4  cells of indicated divi-
sion number (x-axis) is depicted in bar graph (left panel), and flow cytometric data of CD4  events is displayed
(right panel) as cell division (x-axis) versus Annexin V binding (y-axis). Polygonal gate indicates upper limit of
background fluorescence. Results are representative of four separate experiments. 
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visions than what had been achieved in wild-type cells cul-
tured with anti-CD28 (Fig. 1 A), suggesting that intact
CTLA-4 functions even in the presence of maximal
CD28-mediated costimulation.
Genetic confirmation that CTLA-4 regulates cell divi-
sion was recently observed in vivo using recombination ac-
tivating gene (RAG)
 
 
 
/
 
 
 
CTLA-4
 
 
 
/
 
 
 
 TCR transgenic cells
(17). RAG-proficient CTLA-4
 
 
 
/
 
 
 
 TCR transgenic cells,
however, might proliferate differently from normal cells
because they often contain higher percentages of activated
cells (17, 35). To control for such secondary effects within
CTLA-4
 
 
 
/
 
 
 
 cells, and to determine whether the mecha-
nism limiting clonal expansion might be quantitative, we
also studied CTLA-4-haplo-insufficient cells (Fig. 2 B),
which do not have increased numbers of activated cells
(data not shown). We found that CTLA-4
 
 
 
/
 
 
 
 cells had
both increased number of cells and decreased frequency of
apoptosis in later divisions compared with cells from
CTLA-4
 
 
 
/
 
 
 
 littermates. Among CTLA-4-haplo-insuffi-
cient cells, a greater percentage completed six divisions
than did wild-type cells maximally costimulated through
CD28 (Figs. 2 B and 1 A, respectively). Thus, CTLA-4, in
a dose-dependent manner, is a critical regulator of clonal
expansion of CD4
 
 
 
 T cells.
Clonal expansion is regulated at the level of proliferation
and survival (8). We, therefore, tested whether proliferative
arrest could be experimentally separated from apoptosis as a
cause for the decline in cellularity with increasing division.
CD4
 
 
 
 T cells expressing a Bcl-x
 
L
 
 transgene had substan-
tially reduced apoptosis compared with normal cells, but no
significant enhancement of proliferation (Fig. 3 A). In con-
trast, we could correct the proliferative defect in CD28
 
 
 
/
 
 
 
cells by adding rIL-2 (Fig. 3 A), however, few viable cells
remained that could complete the sixth cell division. Thus,
CTLA-4 antagonizes both proliferative and survival signals
mediated by costimulation from CD28, which can be sepa-
rately attributed to the actions of IL-2 and Bcl-x
 
L
 
, respec-
tively (37). In addition, we tested the effect of a relative de-
crease in B7 ligands by stimulating highly purified CD4
 
 
 
cells with immobilized anti-CD3 plus anti-CD28 and rIL-2.
In the absence of antigen-presenting cells, we found that
division-dependent changes in apoptosis were substantially
attenuated (Fig. 3 B).
 
Induction of CTLA-4 Is Coupled to the Cell Cycle.
 
The
precise, invariant regulation of the limits on clonal cell divi-
sion (Figs. 1 and 2) suggested the existence of a cell-auton-
omous mechanism controlling the action of CTLA-4. Ki-
netics of CTLA-4 induction (38, 39), together with the
phenotype of CTLA-4-haplo-insufficiency (Fig. 2 B), fur-
ther suggested that this counterbalance might be regulated
at the level of receptor dosage. We, therefore, examined
the total cellular levels of CTLA-4 in stimulated, proliferat-
ing CD4
 
 
 
 T cells. We found that the levels of CTLA-4
were low in undivided cells, and that levels increased pro-
gressively within the initial cell divisions, achieving maxi-
mal expression after 
 
 
 
3 cell divisions (Fig. 4 A). Addition
Figure 2. CTLA-4 limits clonal expansion of CD4  T cells. (A) CFSE-labeled splenocytes from 3–4-wk-old B10.D2 wild-type (top), CD28 / 
(middle), and CTLA-4 /  (bottom) DO11.10 TCR transgenic mice were stimulated with anti-CD3 mAb (2.0  g/ml) for 4 d. For each genotype,
computation of relative cellularity of live-gated, CD4  cells within each cell division was determined as in Fig. 1 A, and is depicted graphically (left col-
umn). At the time of harvest, and anti-CD4 staining, cells were also resuspended in propidium iodide for determination of cell death (right column).
Flow cytometric data of CFSE dilution (“Cell Division”, x-axis) versus exclusion (lower gate)/inclusion (upper gate) of propidium iodide (y-axis)
among all CD4  events is displayed to the right of cellularity graphs. Numbers above horizontal gates indicate the percentage of dead cells. Results are
representative of three separate experiments. (B) CFSE-labeled splenocytes from 5-wk-old littermate BALB/c CTLA-4 /  (top) and CTLA-4 /  (bot-
tom) DO11.10 TCR transgenic mice were stimulated with anti-CD3 mAb (2.0  g/ml) for 4 d and analyzed identically to the manner described for part
A. Identical results were obtained with cells from B10.D2 littermate-matched pairs of CTLA-4 /  and CTLA-4 /  mice. Results are representative of
four separate experiments. 
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of anti-CD28 and rIL-2, positive regulators of CTLA-4 ex-
pression (39), did not influence the pattern of induction per
cell division but did accelerate its induction in relation to
time, by causing more cells to be represented in later divi-
sions over a fixed time (data not shown).
To further discriminate between time- and division-
dependent controls of expression, we used inhibitors of cell
cycle and monitored CTLA-4 expression in proliferating
or arrested cells cultured for the same length of time. Cells
arrested in G1 using mimosine (40) had defective induc-
tion of CTLA-4 expression (Fig. 4 A). Cells arrested in S
or G2/M had higher levels than cells that had undergone
an earlier arrest, but less than the peak level achieved by
proliferating cells (data not shown). To control for the
specificity of this regulatory pattern, we compared the pat-
tern of expression of CTLA-4 with other molecules associ-
ated with T cell activation. In contrast to CTLA-4, induc-
tion of both CD25 and CD44 was maximal before the first
division and did not achieve any increase with further divi-
sion (Fig. 4 B). Moreover, induction of both CD25 and
CD44, in contrast to CTLA-4, was unimpeded by cell cy-
cle arrest (Fig. 4 B).
CTLA-4 can be recycled between intracellular pools and
the cell surface (39, 41). We, therefore, compared staining
of CTLA-4 in permeabilized cells and unpermeabilized
cells. The intensity of surface CTLA-4 expression in un-
permeabilized cells was in a lower range than intensity of
total cellular expression in permeablized cells. Nonetheless,
surface expression still increased in a step-wise fashion from
lowest levels in undivided cells to highest levels after the
third division (Fig. 4 C).
The division-dependent induction of CTLA-4 in naive
cells, and its more rapid reiteration in immunologically ex-
perienced cells (42), suggested that gene expression might
be regulated by epigenetic mechanisms of repression. To
test this, we cultured cells in the presence of sodium bu-
tyrate, an inhibitor of histone deacetylase (43) that is capa-
ble of derepressing some silent genes. The graded pattern of
total cellular CTLA-4 expression in the initial cell divisions
was substantially increased (Fig. 4, C and D) by the addi-
tion of butyrate. Trichostatin A, a more specific inhibitor
of histone deacetylation, and 5-aza-2-deoxycytidine, an in-
hibitor of cytosine methylation, also caused increases in the
level of CTLA-4 induction within the first three cell divi-
sions (data not shown). Thus, chromatin structure might be
a rate-limiting factor in the induction of CTLA-4.
The augmentation of CTLA-4 expression with agents
that modify chromatin structure and the requirement of
cell cycling to induce CTLA-4 expression suggested that
activation of this gene might be coupled to DNA replica-
tion. To dissect the contributions of cytoplasmic from nu-
clear division, cells were cultured with cytochalasin B,
an inhibitor of actin polymerization (44). Cytochalasin
B–treated cells were unable to undergo cytokinesis (Fig. 4
E), but, in stark contrast to cells arrested in G1 (Fig. 4 A),
were able to express near-maximal levels of CTLA-4 (Fig.
4 E). When we analyzed which cells had undergone gene
induction, we found that the level of CTLA-4 expression
was directly linked to DNA content. Lowest levels of
CTLA-4 expression (4 geometric mean-fluorescence-inten-
sity units above background) were found in cells with 2N
DNA content, and highest levels (61 geometric mean-fluo-
rescence-intensity units above background) were found in
cells with 8N DNA content (Fig. 4 E). It is unlikely this
15-fold increase is due simply to the quadrupling of alleles
as, in a separate analysis, we found that levels of CD25 and
CD44 increased only 4-fold while levels of CTLA-4 in-
creased 13-fold. Thus, CTLA-4 gene expression may be
progressively induced in the first three cell divisions be-
cause of a mechanism coupled to DNA replication. That
such small changes in protein expression between the initial
cell divisions might indeed mediate significant biological
effects is further suggested by the observation that the dif-
ferences in levels of CTLA-4 expression in CTLA-4
 
 
 
/
 
 
 
and CTLA-4
 
 /  cells (Fig. 4 F) were found to closely par-
allel their differences in survival and cell division (Fig. 2 B).
Growth and Maturation Signals Can Counteract the Limits
on Clonal Expansion. During analysis of proliferating
CTLA-4 /  and CTLA-4 /  cells, we noted that CTLA-4
functions in activated cells to limit their size as well as
their proliferation (data not shown). Comparison of cells at
day 4 demonstrated that the over-representation of
Figure 3. Survival and proliferation are antagonized in clonally ex-
panding CD4  T cells. 4 d after stimulation, cells were stained with anti-
CD4 mAb and resuspended in propidium iodide for determination of cell
death. Flow cytometric data of CFSE dilution (“Cell Division”, x-axis)
versus exclusion/inclusion of propidium iodide (y-axis) among all CD4 
events are displayed. Numbers above horizontal gates indicate the per-
centage of dead cells as determined by uptake of propidium iodide. (A)
CFSE-labeled splenocytes from 6-wk-old BALB/c (from left to right)
wild-type, Bcl-xL-transgenic, and CD28 /  DO11.10 TCR transgenic
mice were stimulated with anti-CD3 mAb (2.0  g/ml) for 4 d. Where
indicated (far right panel), human rIL-2 (50 U/ml) was added. (B) In a
separate experiment, splenocytes from 6-wk-old C57BL/6 mice were ei-
ther CD8-depleted (left) or subjected to positive selection ( 98% purity)
of CD4  cells (right) before labeling with CFSE and stimulation with ei-
ther soluble anti-CD3 mAb and anti-CD28 mAb (2.0  g/ml) plus hu-
man rIL-2 (5 U/ml) (left) or plate-bound anti-CD3 mAb and soluble
anti-CD28 mAb (2.0  g/ml) plus human rIL-2 (5 U/ml) (right, “no
APCs”). All results are representative of at least two separate experiments.898 Induction of CTLA-4 as Intrinsic Checkpoint of Helper T Cell Expansion
CTLA-4 /  cells in later cell divisions was accompanied
by increased cell size, as measured by forward light scatter,
in comparison to control cells (Fig. 5 A). This suggested
that CTLA-4 function was restricting not only prolifera-
tion but also cell growth.
Extrinsic growth factor signaling can permit nutrient uti-
lization in T lymphocytes (45). We, therefore, used the pa-
rameters of cell division and cell size to determine whether
the clonal growth arrest mediated by CTLA-4 was a gen-
eral checkpoint in the maturation of CD4  T cell immu-
nity. Because IL-2 expression begins to be downregulated
after approximately three cell divisions (26), we tested
whether saturating levels of rIL-2 could alter the pattern of
growth arrest. Indeed, cells cultured in 200 U/ml of rIL-2
could remain larger and divide more than those cultured in
2 U/ml of rIL-2 (Fig. 5 B). Thus, in the course of an im-
mune response, the presence of survival signals might regu-
late the outcome of clonal expansion.
IL-12 (46, 47) and IL-4 (48, 49) promote growth and
maturation of committed Th1 and Th2 subsets, respec-
tively. We, therefore, examined the effects of IL-12 and
IL-4 on cell division and cell size during polarized im-
mune responses. In the presence of rIL-12, newly differ-
entiating, IFN- –positive, Th1 cells were able to undergo
more division and grow to substantially larger size than
undifferentiated, IFN- –negative cells within the same
culture (Fig. 5 C). In the presence of rIL-4, newly differ-
entiating, IL-4–positive, Th2 cells were able to undergo
more division and grow to substantially larger size than
undifferentiated, IL-4–negative cells in the same culture. A
large proportion of differentiated cells progressed past the
fifth cell division, while only a small fraction of undiffer-
entiated cells could do so (Fig. 5 C). Thus, in subsets of
cells that are specifically responsive, growth signals can
successfully counteract CTLA-4–mediated proliferative-
and growth-arrest.
In human CD4  T cells, expression of CCR7 protein
begins to be downregulated after five cell divisions (30),
giving progeny that achieved greater cell division the
potential to migrate from lymphoid organs to peripheral
tissues (29). To determine whether the pattern of ex-
pression in relation to cell division was similar in the
mouse and, further, whether this was the result of tran-
scriptional repression, we analyzed mRNA levels of
CCR7 using RT-PCR among individual sorted cell
generations of CD4  T cells that had been stimulated in
Th1- and Th2-polarizing conditions (Fig. 5 D). In ei-
ther cytokine milieu, the expression of CCR7 was high-
est in cells that had divided less than five times. After  5
cell divisions levels of CCR7 mRNA became low-to-
undetectable in both cytokine conditions (Fig. 5 D).
Therefore, as is the case in human cells (30), expression
of murine CCR7 in Th cells is regulated by cell divi-
sion. Thus, cytokines that mediate polarization of im-
munity might function to ensure that subsets of effector
T cells can overcome clonal arrest and selectively
Figure 4. Cell cycle–coupled induction
of CTLA-4. (A–E) C57BL/6, CD8-
depleted, CFSE-labeled splenocytes were
stimulated with anti-CD3 (2.0  g/ml) for
3 d. All flow cytometric plots depict only
live-gated, CD4  events. Polygonal gates
are drawn around the upper limit of back-
ground staining, as illustrated in part A. (A)
After culture in the absence (left) or pres-
ence (right) of mimosine (300  M), cells
were fixed, permeabilized, and stained (see
Materials and Methods) with anti-CD4
mAb and either fluorochrome-conjugated
hamster control mAb (top row) or hamster
anti–mouse CTLA-4 mAb (lower row), be-
fore analysis of cell division (x-axis) versus
control staining (top) or total cellular
CTLA-4 expression (bottom) (y-axis). (B)
Cells were washed and stained (without
prior fixation or permeabilization) with ei-
ther anti-CD25, anti-CD44, or control
mAb, before analysis of cell division (x-axis)
versus surface expression (y-axis) of CD25
(left panels) and CD44 (right panels). (C)
Cells were washed, fixed and either stained
directly (“surface,” left panel) or permeabi-
lized before staining (“total,” right panel) as
above. (D) In the same experiment as C, a
group of cells was stimulated in the presence
of sodium butyrate (600  M), to inhibit
histone deacetylases, and analyzed for total cellular CTLA-4 expression (y-axis). (E) Cytochalasin B (3.5  g/ml) was used to prevent cytokinesis in stim-
ulated cells (left panel) before analysis of both DNA content (x-axis, right panel) and CTLA-4 expression (y-axis). (F) Splenocytes from 4 week-old
BALB/c CTLA-4 /  (filled symbols) and CTLA-4 /  (open symbols) littermate mice were stimulated and analyzed as in part A. Geometric mean fluo-
rescence intensity of CTLA-4 expression (y-axis) for each cell generation (x-axis) is displayed. All experiments were performed at least twice.899 Doyle et al.
achieve division numbers (Fig. 5 C) that allow their em-
igration from lymph nodes (2, 29).
Discussion
The present results suggest that the pattern of clonal ex-
pansion of CD4  T cells has a remarkable, and previously
uncharacterized, uniformity in response to a broad range of
stimuli (Fig. 6). After nonpolarizing stimulation, CD4  T
cells clonally expand, reaching an apex of cellularity at ap-
proximately the third cell division. Less than 5% of viable
cells are likely to complete the sixth cell division. This con-
trol over proliferation appears dependent on CTLA-4, and
in its absence, CD4  T cells display unbridled expansion,
due to both excessive cell division and enhanced survival.
Although death receptors may be the final executioner of
those cells undergoing attrition (5–7), our genetic experi-
ments indicate that CTLA-4 alone is sufficient to discrimi-
nate the divisional history of a cell and mark generations for
death or arrest.
Signal transduction through CD28 is likely to be an im-
portant element in this control mechanism for at least two
reasons. First, CD28-deficient T cells, despite a limited
ability to divide, do not undergo clonal expansion in the
presence of an intact CTLA-4 system (Fig. 2 and 3). Sec-
ond, genetic experiments reveal that a deficiency of B7
ligands, which bind both receptors, can correct the auto-
aggressive phenotype of CTLA-4 deficiency (50). Thus,
the gene duplication that gave rise to this pair of receptors
represents an evolutionary “yin-yang” (51), in which the
locus encoding the receptor pair is wholly epistatic.
The unique regulation of CTLA-4 gene expression al-
lows the CD28 receptor, the nondominant member of the
Figure 5. Growth signals can
counteract intrinsic limits on
clonal expansion. In all experi-
ments, T cells were stimulated
for 4 d. All flow cytometric plots
depict only live-gated, CD4 
events. Vertical gates are drawn
before the fifth cell division, and
percentage of cells that achieved
five or more divisions is indi-
cated in left top or bottom cor-
ner. (A) CFSE-labeled spleno-
cytes from 3–4-wk-old B10.D2
CTLA4 /  (top panel) and
CTLA-4 /  (bottom panel)
DO11.10 TCR transgenic mice
were stimulated with anti-CD3
(2.0  g/ml), before staining with
anti-CD4 mAb, and analysis of
CFSE dilution (“Cell Division,”
x-axis) versus forward light scat-
ter (“Cell Size,” y-axis). (B)
CD8-depleted, CFSE-labeled
splenocytes were stimulated with
anti-CD3 in the indicated doses
of human rIL-2 before analysis as
in part A. (C) CD8-depleted, CFSE-labeled splenocytes were stimulated with anti-CD3 (2.0  g/ml), anti-CD28 (0.5  g/ml), rIL-2 (10 U/ml), and ei-
ther rIL-12 (5 ng/ml) plus anti–IL-4 (10  g/ml) (“Th1”conditions, left) or rIL-4 (5 U/ml) plus anti–IL-12 (10  g/ml) (“Th2” conditions, right) before
analysis of intracellular cytokine staining as described in Materials and Methods. Cell division (x-axis) and intracellular accumulation (y-axis) of IFN- 
(left) or IL-4 (right) are depicted in the top row inset. Horizontal gates indicate level of background staining. Cells that were unambiguously cytokine-
negative (middle panels) or cytokine-positive (bottom panels) were further analyzed for cell division (x-axis) and cell size (y-axis) as in part A. (D) Expres-
sion of CCR7 (top panels) and HPRT (bottom panels) was determined by RT-PCR among indicated cell division numbers (“Div. No.”), as described
in Materials and Methods. All results are representative of at least three separate experiments.
Figure 6. CTLA-4 as the central checkpoint of clonal expansion. Spec-
ulative model in which limits imposed on clonal expansion of a precursor
(“P”) CD4  T cell by CTLA-4 expression and function can mediate var-
ious immunologic outcomes. Progressive induction of CTLA-4 during
the initial cell divisions (triangle of dose response) would maintain ho-
meostasis (manifest as anergy or tolerance) in the absence of inflammatory
signals by limiting the division of clonal progeny. In response to a patho-
gen, a subset of clonal progeny may receive growth and maturation sig-
nals that cause further division, enabling their emigration from lymph
nodes. Pathogen-specific clonal progeny that arrest before the fifth divi-
sion could remain in lymphoid niches that may support long-term sur-
vival (memory), perhaps to be rapidly mobilized into further division and
emigration during reinfection.900 Induction of CTLA-4 as Intrinsic Checkpoint of Helper T Cell Expansion
pair for binding B7 (52), to become engaged initially with-
out complete interference from CTLA-4. Counterbalance
from CTLA-4 is then allotted in a precisely controlled
manner by the cell cycle and its ability to permit gene in-
duction in proportion to proliferation. We are still deter-
mining whether there is actual repression in cis at the
CTLA-4 locus, in trans at the locus of an activator of the
CTLA-4 promoter, or some other explanation for the graded,
division-dependent gene induction. Nonetheless, cell cy-
cle–coupled regulatory and epigenetic effects might be the
mechanistic explanation for what others have recently rec-
ognized as a level of cell-autonomous control in the way
lymphocytes respond to extrinsic signals (2, 4).
There are surely some redundant or cooperative negative
controls for CD4  T cells since CTLA-4 /  cells do not
behave as though immortalized. These are likely to be the
death receptors and the in vivo limitations or niches that
permit survival or growth, such as nonpolarizing and polar-
izing cytokines. The phenotype of cells with CTLA-4 defi-
ciency that have been stimulated in vitro is strikingly simi-
lar to the behavior of wild-type Th1 cells cultured in IL-12
or wild-type Th2 cells cultured in IL-4. These results sup-
port a model in which programming of selective growth
factor reception (46–49) is a proximate event in effector
lineage commitment (53). Early in differentiation, Th1
cells become uniquely programmed for IL-12R 2 expres-
sion (53–55), and Th2 cells become uniquely competent in
IL-4R signal transduction (56, 57). Subsets of differentiated
cells might, therefore, receive selective signaling from the
cytokine milieu to progress to a CCR7-negative stage and
thereby mediate immunity in tissues (Fig. 6). This check-
point, thus, sharpens polarity from cytokines, and also re-
stricts important fate transitions in the effector and memory
response (2, 29, 30).
Our results may provide insight into the elusive basis of
long-lived immunologic memory, as well as the unusual
auto-aggressive phenotype of CTLA-4–null mice, wherein
peripheral tissues are the primary targets of inflammation.
The limitation on the number of divisions a cell undergoes,
provided by CTLA-4 (Fig. 6), may ensure a long-lived
remnant of CCR7-positive clonal progeny in central lym-
phoid compartments, which can be rapidly mobilized dur-
ing rechallenge (58, 59). If T cells are fated to linear, termi-
nal differentiation as they divide, a proliferative arrest of
some progeny may be the only way to maintain self-
renewal of clonally selected cells. The substantial increase
in division number that is readily achieved by CTLA-4–
deficient cells would, therefore, be compatible with pre-
dominantly peripheral tissue inflammation (Fig. 6).
In double-positive thymocytes, variations in signal trans-
duction through the antigen receptor are integrated into
vastly different outcomes by intrinsic rheostats, such as
Grb2 (60). In the periphery, where TCR signaling is cou-
pled to proliferation, and perhaps obligatory for survival
(61–63), CTLA-4 gene induction and function appears to
be an intrinsic rheostat that may be a central checkpoint of
antigen-driven clonal expansion (Fig. 6). Further matura-
tion and expansion might then become dependent on
nonantigenic extrinsic signals, such as those provided by in-
flammatory cytokines, which can mediate avoidance of
clonal arrest.
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